They plan on 30 million doses being available by September, granted their current trials continue to show promise. But it's encouraging that the initial trials have been positive enough that they are mass producing in anticipation that it will be approved by September. It will likely still take a few months after before it's really accessible worldwide but there are several companies, including two in the USA, that believe they will have one by fall.
